Noesis Pharma Clinical Trials — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

NoesisPharma is a private, physician-owned clinical research site founded in 2010 (with operational data suggesting 2015) and based in Phoenix, Arizona. The company provides clinical trial services for Phase II-IV studies, with a core therapeutic focus on psychiatry and CNS disorders. Led by its founder and Medical Director, Dr. Lee Ann Kelley, the organization leverages a team with decades of combined clinical and research experience to conduct trials for external biopharma sponsors, operating under a fee-for-service business model.

PsychiatryCentral Nervous System (CNS)

Technology Platform

Operational platform for clinical trial execution, including patient recruitment, protocol management, and data collection in compliance with FDA, CFR, and ICH-GCP guidelines. Relies on experienced medical staff and standardized procedures rather than proprietary technology.

Opportunities

Growing sponsor demand for specialized CNS trial sites and high-quality data.

Potential to expand service offerings or form alliances with clinical research networks to access a broader portfolio of studies.

The significant unmet need in psychiatry ensures continued R&D investment in the sector.

Risk Factors

High dependency on successful patient recruitment and retention for each contracted trial.

Operational concentration as a single-site entity creates geographic and scalability risks.

Revenue is entirely tied to a limited number of sponsor contracts, subject to the cyclical nature of biopharma R&D spending.

Competitive Landscape

Competes with other dedicated clinical research sites, academic medical centers, and large national/international Contract Research Organizations (CROs) for sponsor contracts. Differentiation is based on therapeutic expertise in CNS, physician involvement, quality of data, and patient care reputation within the local Phoenix market.

More companies in Digital Health & Biotech SaaS →More companies in United States →